Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Depreciation & Amortization (CF) (2020 - 2025)

Bio Essence (BIOE) has 6 years of Depreciation & Amortization (CF) data on record, last reported at $58.0 in Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) fell 1.69% year-over-year to $58.0; the TTM value through Sep 2025 reached $234.0, up 114.73%, while the annual FY2024 figure was $911.0, 80.99% down from the prior year.
  • Depreciation & Amortization (CF) reached $58.0 in Q3 2025 per BIOE's latest filing, down from $59.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $15291.0 in Q3 2022 and bottomed at -$23155.0 in Q4 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $2957.6, with a median of $2327.0 recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): plummeted 336.28% in 2022, then soared 102.38% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $9800.0 in 2021, then crashed by 336.28% to -$23155.0 in 2022, then skyrocketed by 89.45% to -$2442.0 in 2023, then skyrocketed by 102.38% to $58.0 in 2024, then changed by 0.0% to $58.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $58.0 in Q3 2025, $59.0 in Q2 2025, and $59.0 in Q1 2025.